SCHEMBL1636738

SCHEMBL1636738

COc1ccc(NS(=O)(=O)CC(=O)O)cc1S[Si](C)(C)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.39
WDR5 P61964 1/20 0.36
FABP4 P15090 4/20 0.36
GAA P10253 2/20 0.36
MAPT P10636 1/20 0.36
SMN1; SMN2 Q16637 3/20 0.35
LMNA P02545 2/20 0.35
HTT P42858 2/20 0.35
ALOX15 P16050 2/20 0.35
MAPK1 P28482 1/20 0.35
LY6K Q17RY6 1/20 0.35
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TSHR P16473 2/20 0.34
HDAC8 Q9BY41 1/20 0.34
ALPL P05186 1/20 0.34
POLB P06746 1/20 0.34
ALPI P09923 1/20 0.34
ALPG P10696 1/20 0.34
HPGD P15428 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1635107 0.81 CYP1A2 (0.41) SMN1; SMN2LMNAMEN1KMT2ATSHR
SCHEMBL1635181 0.80 SMN1; SMN2 (0.41) L3MBTL1WDR5FABP4SMN1; SMN2LMNA
SCHEMBL1635370 0.79 CA5A (0.38) L3MBTL1GAAMAPTHTTMAPK1
SCHEMBL831093 0.77 GAA (0.51) L3MBTL1FABP4GAASMN1; SMN2LMNA
SCHEMBL1636450 0.74 L3MBTL1 (0.43) L3MBTL1FABP4GAAMAPTSMN1; SMN2
SCHEMBL1122405 0.74 LMNA (0.48) L3MBTL1FABP4MAPTLMNAHTT
SCHEMBL2244136 0.74 CA1 (0.47) L3MBTL1GAAMAPTSMN1; SMN2LMNA
SCHEMBL1635509 0.71 GAA (0.35) GAAMAPTTSHRPOLBHPGD
SCHEMBL2212133 0.71 ALDH1A1 (0.56) L3MBTL1GAAMAPTSMN1; SMN2LMNA
SCHEMBL829810 0.68 CA1 (0.54) L3MBTL1GAASMN1; SMN2LMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3138832-A1 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University - Of The Commonwealth System of Higher Education (US) 2017-03-08 EP disclosed
US-7932242-B2 Anticancer agents; radiation and chemical resistance TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2011-04-26 US disclosed
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2008-03-06 US disclosed
EP-1740530-A4 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS UNIV TEMPLE (US) 2008-02-27 EP disclosed
EP-1740530-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS Temple University of the Commonwealth System of Higher Education (US) 2007-01-10 EP disclosed
WO-2005089269-A2 SUBSTITUTED PHENOXY- AND PHENYLTHIO- DERIVATIVES FOR TREATING PROLIFERATIVE DISORDERS TEMPLE UNIVERSITY - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) 2005-09-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058290-A1 Substituted Phenoxy-and Phenylthio-Derivatives for Treating Proliferative Disorders PCNA, MKI67, TP53 L3MBTL1 2021/4885WDR5 2340/4885FABP4 1822/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.